The landscape of cancer treatment is constantly evolving, with new evidence and clinical findings emerging at a rapid pace. The Oncology Pharmacists Connect conference, developed in partnership with the Hematology/Oncology Pharmacy Association (HOPA), is specifically designed for oncology pharmacists to navigate the gaps between research and real-world practice. This one-and-a-half-day meeting features accredited continuing education sessions, interactive roundtables, and panel discussions, allowing attendees to engage directly with clinical specialists, managed care experts, and oncology pharmacists to discuss recently presented data, identify resources needed to successfully implement new therapies and make formulary decisions, examine challenges, and brainstorm solutions to meet organizational demands while improving patient outcomes. This collaborative format is designed to facilitate debate, shared problem-solving, and the exchange of best practices. The agenda has been carefully curated to focus on the most impactful data presented at the American Society of Clinical Oncology (ASCO) Annual Meeting and the European Hematology Association (EHA) Hybrid Congress.

Attendance Notice

Oncology Pharmacists Connect is a specialized in-person educational meeting dedicated to advancing collaboration, innovation, and excellence in hematology-oncology pharmacy practice. The program is developed for licensed pharmacists who provide direct patient care, offering evidence-based discussions and clinical insights that translate research into improved patient outcomes.

To preserve the integrity of these peer-to-peer discussions, attendance is reserved for pharmacists in clinical or patient-facing roles. Individuals employed by pharmaceutical, biotechnology, device, or diagnostic companies may participate only through approved opportunities designated for industry engagement.

For sponsorship opportunities or questions regarding eligibility, please contact OPC@pharmacytimes.com.